Twist Bioscience Corporation (TWST)

Twist Bioscience Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	286.47	378.69	465.83	93.67	46.74
Short-Term Investments	49.94	126.28	12.03	196.34	91.37
Cash & Cash Equivalents	336.41	504.97	477.86	290	138.11
Cash Growth	-33.38%	5.67%	64.78%	109.98%	71.02%
Receivables	44.06	40.29	28.55	26.38	12.1
Inventory	32.06	39.31	31.8	12.29	7.33
Other Current Assets	11.72	11.91	8.28	6.2	2.59
Total Current Assets	424.26	596.48	546.5	334.87	160.14
Property, Plant & Equipment	203.36	214.39	105.7	59.17	20.84
Long-Term Investments	2.81	1.57	1.53	0.58	0.58
Goodwill and Intangibles	140.29	145.55	40.7	1.45	1.65
Other Long-Term Assets	5.68	3.39	7.67	2.82	3.8
Total Long-Term Assets	352.15	364.9	155.6	64.01	26.86
Total Assets	776.4	961.38	702.1	398.88	186.99
Accounts Payable	14.05	20.09	14.9	4.83	9.76
Current Debt	14.9	13.64	9.77	9.74	3.33
Other Current Liabilities	44.38	56.93	38.39	21.46	17.26
Total Current Liabilities	73.32	90.66	63.05	36.03	30.35
Long-Term Debt	79.17	81.27	53.16	26.24	4.4
Other Long-Term Liabilities	0.48	0.06	5.07	0.35	0.16
Total Long-Term Liabilities	79.65	81.33	58.22	26.59	4.56
Total Liabilities	152.97	171.99	121.28	62.62	34.91
Total Debt	94.07	94.91	62.92	35.98	7.73
Debt Growth	-0.89%	50.84%	74.87%	365.30%	-20.43%
Retained Earnings	-1,033.03	-828.42	-610.55	-458.46	-318.52
Comprehensive Income	-0.76	-1.84	0.55	0.09	0.18
Shareholders' Equity	623.43	789.39	580.82	336.26	152.08
Net Cash / Debt	242.34	410.06	414.94	254.02	130.37
Net Cash / Debt Growth	-40.90%	-1.18%	63.35%	94.84%	83.52%
Net Cash Per Share	4.26	7.61	8.60	6.48	4.75
Working Capital	350.93	505.82	483.44	298.84	129.78
Book Value Per Share	10.96	14.65	12.04	8.58	5.54

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).